Willy Michel
Direttore/Membro del Consiglio presso ADVAL TECH HOLDING AG
Patrimonio netto: 4 470 M $ in data 31/05/2024
Posizioni attive di Willy Michel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ADVAL TECH HOLDING AG | Direttore/Membro del Consiglio | 20/05/2021 | - |
| Presidente | 25/07/2012 | 01/01/2019 | |
BV Holding AG
 BV Holding AG Investment ManagersFinance BV Holding AG engages in the provision of equity financing. It invests in other companies with the goal of value creation. The company was founded on April 8, 1997 and is headquartered in Gumligen, Switzerland. | Direttore/Membro del Consiglio | 01/03/2008 | - |
| Presidente | 01/01/2001 | 15/03/2012 | |
| Faes Bau AG | Direttore/Membro del Consiglio | 26/11/2010 | - |
Techpharma Management AG
 Techpharma Management AG Financial ConglomeratesFinance Techpharma Management AG engages in the provision of services to affiliated firms and the operation of hotels. Its services include the provision of real estate for use, and advice on management, financing and investment issues, as well as the administration of hotels and restaurants, in particular the Hotel Stadthaus, the Hotel Berchtold and the Restaurant Schützenhaus in Burgdorf. The company was founded on May 4, 2000 and is headquartered in Burgdorf, Switzerland. | Presidente | - | - |
| Diabetes Center Berne Foundation | Presidente | 01/06/2017 | - |
| Fondatore | 01/06/2017 | - | |
Adval Tech Holding (Germany) GmbH
 Adval Tech Holding (Germany) GmbH Financial ConglomeratesFinance Part of Adval Tech Holding AG, Adval Tech Holding (Germany) GmbH provides investment services. The company is based in Endingen am Kaiserstuhl, Germany. René Rothen has been the CEO of the German company since 2012. | Presidente | - | - |
Storia della carriera di Willy Michel
Precedenti posizioni note di Willy Michel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| YPSOMED HOLDING AG | Presidente | 29/12/2003 | 29/06/2022 |
| Fondatore | 29/12/2003 | 29/06/2022 | |
Finox Biotech AG
 Finox Biotech AG Medical/Nursing ServicesHealth Services Finox AG specializes in developing fertility drugs. Its products include BEMFOLA, a recombinant-human follicle-stimulating hormone. The company was founded by Michel Wilhelm in 2007 and is headquartered in Burgdorf, Switzerland. | Presidente | 01/01/2007 | 01/07/2016 |
| Fondatore | 01/01/2007 | 01/07/2016 | |
| Finox Beteiligungen AG | Corporate Officer/Principal | 26/11/2010 | 16/09/2013 |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | - | ░░░░░░░░░░ | |
| ░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░ ░░░░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Statistiche
Distribuzione geografica
| Svizzera | 15 |
| Germania | 2 |
Posizioni
| Chairman | 10 |
| Founder | 5 |
| Director/Board Member | 4 |
Settori
| Health Technology | 6 |
| Finance | 5 |
| Producer Manufacturing | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ADVAL TECH HOLDING AG | Producer Manufacturing |
| YPSOMED HOLDING AG | Health Technology |
| Aziende private | 13 |
|---|---|
BV Holding AG
BV Holding AG Investment ManagersFinance BV Holding AG engages in the provision of equity financing. It invests in other companies with the goal of value creation. The company was founded on April 8, 1997 and is headquartered in Gumligen, Switzerland. | Finance |
| Finox Beteiligungen AG | Finance |
| Faes Bau AG | |
Novo Nordisk Pharma AG
 Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Health Technology |
| Disetronic Medical Systems AG | |
Ziemer Group AG
 Ziemer Group AG Medical SpecialtiesHealth Technology Ziemer Group AG develops, manufactures, and markets diagnostic and surgical ophthalmic products. Its products include FEMTO LDV, AMADEUS, GALILEI and PASCAL. The company was founded by Frank Ziemer in 1998 and is headquartered in Port, Switzerland. | Health Technology |
Finox Biotech AG
Finox Biotech AG Medical/Nursing ServicesHealth Services Finox AG specializes in developing fertility drugs. Its products include BEMFOLA, a recombinant-human follicle-stimulating hormone. The company was founded by Michel Wilhelm in 2007 and is headquartered in Burgdorf, Switzerland. | Health Services |
| Museum Franz Gertsch | |
Techpharma Management AG
Techpharma Management AG Financial ConglomeratesFinance Techpharma Management AG engages in the provision of services to affiliated firms and the operation of hotels. Its services include the provision of real estate for use, and advice on management, financing and investment issues, as well as the administration of hotels and restaurants, in particular the Hotel Stadthaus, the Hotel Berchtold and the Restaurant Schützenhaus in Burgdorf. The company was founded on May 4, 2000 and is headquartered in Burgdorf, Switzerland. | Finance |
Disetronic Holding AG
 Disetronic Holding AG Medical SpecialtiesHealth Technology Disetronic Holding AG manufactured medical products for treatment of diabetes. The company infusion business was integrated into the Roche Diabetes Care Business Area within the Roche Diagnostics Division. Founded in 1990, the company was headquartered in Burgdorf, Switzerland. | Health Technology |
Fertility Biotech AG
 Fertility Biotech AG BiotechnologyHealth Technology Fertility Biotech AG is a holding company, which engages in the development, production, and distribution of medicines. The company was founded on June 7, 2016 and is headquartered in Burgdorf, Switzerland. | Health Technology |
| Diabetes Center Berne Foundation | |
Adval Tech Holding (Germany) GmbH
Adval Tech Holding (Germany) GmbH Financial ConglomeratesFinance Part of Adval Tech Holding AG, Adval Tech Holding (Germany) GmbH provides investment services. The company is based in Endingen am Kaiserstuhl, Germany. René Rothen has been the CEO of the German company since 2012. | Finance |
- Borsa valori
- Insiders
- Willy Michel
- Esperienza
